Inventor
GARRAWAY LEVI A
US13 patents
⚠️ This page may combine multiple inventors who share the name “GARRAWAY LEVI A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
7 patentsUS9629839B2Apr 25, 2017
C-RAF mutants that confer resistance to RAF inhibitors
DANA FARBER CANCER INST INC2 citations68
US12146196B2Nov 19, 2024
C-RAF mutants that confer resistance to RAF inhibitors
DANA FARBER CANCER INST INC0 citations58
US11788151B2Oct 17, 2023
C-RAF mutants that confer resistance to RAF inhibitors
DANA FARBER CANCER INST INC0 citations58
US11789022B2Oct 17, 2023
MEK1 mutation conferring resistance to RAF and MEK inhibitors
DANA FARBER CANCER INST INC0 citations57
US12522872B2Jan 13, 2026
Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
DANA FARBER CANCER INST INC0 citations56
US11186874B2Nov 30, 2021
ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors
DANA FARBER CANCER INST INC0 citations52
US10788496B2Sep 29, 2020
MEK1 mutation conferring resistance to RAF and MEK inhibitors
DANA FARBER CANCER INST INC0 citations47
GARRAWAY LEVI A
3 patentsUS11078540B2Aug 3, 2021
Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
GARRAWAY LEVI A0 citations53
US9880169B2Jan 30, 2018
MEK1 mutation conferring resistance to RAF and MEK inhibitors
GARRAWAY LEVI A0 citations44
US9084781B2Jul 21, 2015
MEK mutations conferring resistance to MEK inhibitors
GARRAWAY LEVI A0 citations36